DNMT3L and hepatocellular carcinoma: To explore whether DNMT3L regulates the malignant cell phenotype of HCC through CDO1, we assessed whether inhibiting CDO1 could reverse the effects of DNMT3L overexpression on the biological behaviors of hepatoma cells.